Amperometric Sensor for 3-hydroxybutyrate Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current analyte sensor systems, particularly for diabetic patients, lack the ability to continuously monitor ketone levels, such as 3-hydroxybutyrate, which is crucial for preventing diabetic ketoacidosis, as they are not designed for continuous in vivo measurement and face challenges with enzyme cofactor management and mediator toxicity.
Innovation Solution
Development of amperometric analyte sensor systems with a 3-hydroxybutyrate sensing electrode comprising a constellation of elements including 3-hydroxybutyrate dehydrogenase enzyme, nicotinamide adenine dinucleotide (NAD+/NADH) cofactor, and a mediator, tethered to a polymer like polyvinyl pyridine, embedded in a screen-printed carbon electrode, to facilitate continuous monitoring of 3-hydroxybutyrate and glucose levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional fingerstick strip and meter methods are used for ketone testing, then measurement is possible, but continuous monitoring capability is lost
Solution Approach 1:
The patent replaces the mechanical fingerstick strip method with an electrochemical amperometric sensor system that uses electron transfer reactions to detect 3-hydroxybutyrate. The sensor incorporates 3-hydroxybutyrate dehydrogenase enzyme, NAD+/NADH cofactor, and a mediator that transfers electrons to the electrode, enabling continuous in vivo monitoring rather than discrete manual measurements
Solution Approach 2:
The sensor system is designed to be self-sufficient with all components (enzyme, cofactor, mediator) tethered within the sensor matrix, eliminating the need for external reagent replenishment or manual intervention. The system autonomously performs continuous monitoring by maintaining the enzymatic reaction and electron transfer processes internally
2Measurement precision
If mediator is used to facilitate electron transfer, then electrochemical detection is enabled, but mediator leaching and toxicity occur
Solution Approach 1:
The patent uses a composite sensor matrix that incorporates the mediator within a polymeric structure (such as polyvinyl pyridine or Nafion). This composite approach allows the mediator to be physically entrapped and chemically tethered to the matrix, preventing leaching while maintaining its electrochemical function. The composite structure provides both the necessary electron transfer capability and the containment mechanism to eliminate toxicity concerns
Solution Approach 2:
The patent employs a mediator molecule (such as osmium complexes, ferricenium salts, or quinones) that acts as an intermediary between the enzymatic reaction and the electrode. The mediator is specifically designed to be tethered to the sensor matrix through covalent bonding or strong adsorption, allowing it to shuttle electrons without leaching into the biological environment, thus resolving the toxicity problem while preserving the electrochemical detection capability
3Adaptability or versatility
If enzyme and cofactor are incorporated for 3-hydroxybutyrate detection, then specific sensing is achieved, but enzyme reaction stoichiometry management becomes complex
Solution Approach 1:
The patent combines the enzyme (3-hydroxybutyrate dehydrogenase), cofactor (NAD+/NADH), and mediator into a single integrated sensor matrix. This merging of components eliminates the need for separate management of each element's stoichiometry, as they all function together within the confined sensor environment. The tethering strategy ensures fixed ratios and prevents loss, simplifying the overall system management while maintaining specific sensing capability
4Productivity
If amperometric sensing is implemented for continuous monitoring, then real-time data is obtained, but mediator toxicity and leaching issues arise
Solution Approach 1:
The patent employs composite material structures where the mediator is embedded within a polymeric matrix (such as polyvinyl pyridine, Nafion, or other ion-exchange membranes). This composite structure enables continuous amperometric monitoring by maintaining mediator availability for electron transfer while simultaneously preventing mediator leaching into the biological environment, thus eliminating toxicity concerns
Solution Approach 2:
The patent uses specifically designed mediator molecules (such as osmium bipyridine complexes, ferricenium salts, or quinone derivatives) that are tethered to the sensor matrix. These mediators facilitate continuous electron transfer for real-time monitoring while their tethered state prevents them from leaching into the body, resolving the toxicity problem that would otherwise limit continuous amperometric sensing
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables continuous and accurate monitoring of 3-hydroxybutyrate and glucose levels, preventing diabetic ketoacidosis by providing self-sufficient, tethered chemistry that inhibits mediator leaching and maintains enzyme reaction stoichiometry, thereby enhancing patient safety and management of diabetes.
Implementation Method 1
an enzyme layer comprising 3-hydroxybutyrate dehydrogenase enzyme in operable contact with the electroactive material
Implementation Method 2
a nicotinamide adenine dinucleotide (NAD+/NADH) cofactor in operable contact with the 3-hydroxybutyrate dehydrogenase enzyme
Implementation Method 3
a mediator in operable contact with the nicotinamide adenine dinucleotide
Implementation Method 4
amperometric analyte sensor systems comprising a 3-hydroxybutyrate sensing electrode
Implementation Method 5
a 3-hydroxybutyrate modulating layer that comprises a composition that modulates the diffusion of 3-hydroxybutyrate therethrough
Data Source
AI summary
The invention provides amperometric analyte sensor systems comprising one or more electrodes designed to monitor in vivo levels of 3-hydroxybutyrate (and optionally glucose as well) in order to facilitate the management of diabetic ketoacidosis. The invention further includes compositions, elements and methods useful with such amperometric analyte sensor systems.